chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Received HIB #4 on Right deltoid on 4/7/03; redness and slight swelling started 4/8/03 AM, increased on Wed. 4/9/03, to include upper arm; F-ROM, nothing found, playful. 4/15/03: swelling and redness gone - purplish coloration, small at site remains, getting better.
Rapid heart rate for 24 hours (125-130); Fever; Dizziness; Weakness; Tired; This is a spontaneous report from a non-contactable consumer, the patient. An 18-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 10Aug2021 at 15:00 (at the age of 18-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included sertraline hydrochloride (ZOLOFT) and levocabastine hydrochloride (ZYRTEC) both started from an unknown date for an unknown indication and unknown if ongoing. On 10Aug2021 at 19:00, the patient experienced rapid heart rate for 24 hours (125-130), fever, dizziness, tired and weakness. The events resulted in emergency room/department or urgent care. Therapeutic measures were not taken as a result of events. On 10aug2021 at 19:00, the patient underwent heart rate test and the result was 125-130. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events rapid heart rate for 24 hours (125-130), fever, weakness, dizziness, tired were not recovered at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
covid-like symptoms, shortness of breat, dry couhg, body aches, fevers over 102
COVID-19; COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from product quality group.  A 59-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 18Dec2020 as dose 1, single (Lot number: EK5730), in left arm, on 08Jan2021 as dose 2, single (Lot number: EK5730), in left arm, on 16Nov2021 as dose 3 (booster), single (Lot number: FF2593), in left arm and on 16Jun2022 as dose 4 (booster), single (Lot number: FM2593) at the age of 59 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "CKD" (unspecified if ongoing); "HTN" (unspecified if ongoing); "Depression" (unspecified if ongoing); "Anxiety" (unspecified if ongoing); "Hypo-Para-Thyroidism" (unspecified if ongoing). Concomitant medication(s) included: WELLBUTRIN XL, start date: 01Mar2002; ENALAPRIL; PROGESTERONE ABBOTT; CEPHALEXIN [CEFALEXIN]; CALCIUM CITRATE; LORAZEPAM; CALCITRIOL; CHLORTHALIDONE; KLOR-CON; LIPITOR; NATURE MADE VITAMIN D3; TURMERIC [CURCUMA LONGA]; CRANBERRY; METHOCARBAMOL. The patient had no known allergies. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID-19". Therapeutic measures were taken as a result of vaccination failure, covid-19. Anti-viral details (COVID-19 Treatment): PAXLOVID from 03Oct2022 to 05Oct2022.
Shot 2 - Uncontrollable muscle spasms and shaking lasting for 30-45 minutes occurred approximately 14 hours after the shot.  I was flopping like a fish out of water on my bed.  The spasms caused me to feel like throwing up but I didn't.  For 10-15 minutes the shaking/spasms were so severe that I could not get out of bed.  After about 20 -25 minutes, I could feel the shaking/spasms were getting less severe.  Had they continued longer, I may have needed to call EMTs.  After another 30 minutes or so, I was able to return to sleep with no other incidents. Shot 1 - I don't know if this was a reaction to shot 1 or not but my doctor thought it might be and encouraged me to report it.  Note that my first dose was given on 4/20/2021 at approximately 10:40 am.  A day or 2 later, I noticed about 20 red blotches on my right leg, between the knee and ankle.  It appered that some small blood vessels may have ruptured under the skin.  There was no active blood through the skin, just the red circles under the skin.  A few days later, 2 red blotches similar to those on my right leg appeared on my left leg.
Erythematous skin lesions, noted 9/19/04. PE erythematous papulo-vesicular lesions on trunk and  ext and on hairline lesions sparse. Benadryl for itching.
Redness and swelling at site which progressed to blisters. Low grade fever at home. On exam, T=100F, 7cm x 9cm area of erythema, tenderness, induration right lateral thigh (inj site) with 5cm x 5cm central area of blisters, largest 3mm. Treated as cellulitis with cephalexin.
Couldn't raise arm above 90 degrees or more lateral such as washing hair. Felt like "rotator cuff injury would feel like I imagine." No redness, swelling, or bruising at site but thought it felt hard like a spasm. Lasted 1 week - never took anything. Heating pad used.
My left foot felt very heavy then my left lower leg started to get numb.  We  all 911 by the time the ambulance came  my left arm was  getting numb.   I was transported in helicopter to  regional Hospital  I was having a stroke
Patient reported on next morning (8/19/20) after administration that he thought he was having an adverse reaction to the vaccines as he had fever, chills, body aches, fatigue and his right arm hurt (including around the arm -trap area, armpit)-he described pain around lymphnodes. His temp was measured again and it was 98.6. He went home sick from work. His spouse then called on 8/20/20 & indicated that he had been alternating w/tylenol/advil to keep fever down but it kept going up to 102-103 degrees using ear thermometer (she questioned the accuracy of the thermometer). I advised  to call MD and test for COVID-referred them to Urgent Care. He asked for records to be sent to md-resent them this time via fax on 8/20/20.
I received my COVID-19 vaccine on 09/04/2022. After I felt a little fatigue for the next 3 days. On the third day I felt as is my blood pressure elevated, heart rate increased and I started feeling "spacy" in the head . I went to get an EKG. I was refereed to an cardiologist because of my elevated heart rate. I was diagnosed with tachycardia, and other fatigue . I am still feeling fatigue and spacy.
Chills; Shortness of breath; Extreme fatigue; Loss of appetite; Frequent urination (q 20-30 minutes); Cold sweats; This is a spontaneous report received from a contactable reporter(s) (Physician). The reporter is the patient.  A 78 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 29Sep2021 12:45 (Lot number: FF8839) at the age of 78 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Heart disease" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: EN6205, Location of injection: Arm Left, Vaccine Administration Time: 10:00 AM), administration date: 13Mar2021, when the patient was 78 years old, for COVID-19 immunization; Bnt162b2 (Dose Number: 1, Batch/Lot No: EN6201, Location of injection: Arm Left, Vaccine Administration Time: 08:00 AM), administration date: 20Feb2021, when the patient was 78 years old, for COVID-19 immunization. The following information was reported: CHILLS (non-serious) with onset 29Sep2021 23:00, outcome "recovered" (2021), described as "Chills"; DYSPNOEA (non-serious) with onset 29Sep2021 23:00, outcome "recovered" (2021), described as "Shortness of breath"; FATIGUE (non-serious) with onset 29Sep2021 23:00, outcome "recovered" (2021), described as "Extreme fatigue"; DECREASED APPETITE (non-serious) with onset 29Sep2021 23:00, outcome "recovered" (2021), described as "Loss of appetite"; POLLAKIURIA (non-serious) with onset 29Sep2021 23:00, outcome "recovered" (2021), described as "Frequent urination (q 20-30 minutes)"; COLD SWEAT (non-serious) with onset 29Sep2021 23:00, outcome "recovered" (2021), described as "Cold sweats". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of chills, dyspnoea, fatigue, decreased appetite, pollakiuria, cold sweat. Additional information: No other vaccine was given in four weeks. The patient did not have Covid prior to vaccination. Covid tested was performed post vaccination.  No follow-up attempts are possible. No further information is expected.
No adverse reactions to note. Vaccine given 2 weeks after the first, instead of 4 weeks.
After a week my right bicep deltoid area became sore and painful.   Saw the doctor on 2/2 /21 but never thought this was related to the vaccine. Pain radiates down arm, entire shoulder blade and rotator cuff. Burning sensation down right arm which has subsided a bit.  Still major pain, unable to treat with success
Severe swelling of left shoulder, hard and hot to touch for 4 days. Developed high fever for 30 hours. Developed severe headache - postherpetic neuralgia - along same path/location as previous shingles outbreak from 11 years ago. This pain lasted for 7 days
This spontaneous report was received from a physician refers to a 62 year old male patient. The patient's medical history included shingles with post herpetic neuralgia. On an unknown date, the patient was vaccinated with ZOSTAVAX, (0.65 ml) subcutaneous. On an unknown date, within one hour after vaccination with ZOSTAVAX, the patient experienced pruritus and erythema at the injection site and also on trunk and right leg. On an unknown date, after 24 hours after vaccination with ZOSTAVAX, the patient experienced slight induration at the injection site; about 1 to 1.5 cm in diameter, there was one lesion on his trunk, multiple lesions on the inner aspect of his right thigh and one lesion on his left leg. The physician stated that these lesions were uniform and they are not papules. The physician stated that he believe that it looks like early shingles. The patient sought medical attention and visited the physician office. The physician also stated that he has already filed a report with VAERS. The physician offer of VZV packet. The outcome of the events was reported as not recovered. The reporter did not provide the causality between the event and the suspect drug. Additional information has been requested.
On 3/6/01, pt's left arm (which was the arm in which she recvd injection) swelled, and she experienced malaise. Later in the evening, pt became "ill" and was sweating, nauseous (vomited), had "irritable bowel syndrome" (not confirmed by MD). On the following day, pt's arm was still swollen, she was still "sick" and could not get out of bed or eat. The swelling then went up to the elbow and a rash occurred on her upper arm. On 3/12/01, pt recovered from the arm swelling and malaise and all of the pt's other "symptoms" resolved after 3-4 days. Addtl info is not expected. Of note, the pt reported that the vaccine was administered and symptoms began on 3/7/01 rather than 3/6/01 as reported by MD.
Within 24 hours post vax, the pt developed a rash at the injection site. The rash developed into erythema multiforme and spread from head to toe. FU info indicates rash developed at injection site and also a welt developed
Patient  feeling  light headedness with sweats. upon arriving to vehicle patient reported immediately feeling better and was advised to notify medical staff of any worsening symptoms and to wait full 15 minutes until leaving premisses
LEFT ARM WEAKNESS; PAIN ON LEFT ARM AND FINGERS; CAN'T SLEEP BECAUSE OF PAIN; This spontaneous report received from a patient concerned a 49 year old male. The patient's height, and weight were not reported.  The patient's past medical history included kidney stone surgery, and concurrent conditions included non-alcohol user, and non-smoker, and other pre-existing medical conditions included the patient had no known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 205A21A expiry: UNKNOWN) dose was not reported, administered on 19-MAY-2021 for prophylactic vaccination.  No concomitant medications were reported.  On 20-MAY-2021, the subject experienced can't sleep because of pain. On 20-MAY-2021, the subject experienced pain on left arm and fingers. On 15-JUN-2021, the subject experienced left arm weakness. Laboratory data (dates unspecified) included: Blood test (NR: not provided) Not reported.  Treatment medications (dates unspecified) included: gabapentin, and ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from left arm weakness, can't sleep because of pain, and pain on left arm and fingers. This report was non-serious. This case, from the same reporter is linked to 20210760712.
Wrong vaccine was given. Patient should have received the monoclonal antibody Nirsevimab.   Patient did NOT have any adverse effects after administration.
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 14-APR-2016 the patient was vaccinated with an improperly stored dose of VAQTA 10Pk 50U/1ml (lot # L017757, expiration date 08-APR-2018, dose and route were unspecified). This specified lot number vaccine was exposed to temperature excursion twice. The total cumulative excursion time of the first time was 168 hours with the lowest recorded temperature of 33 Fahrenheit. The total cumulative excursion time of the second time was 384 hours with the lowest recorded temperature of 34 Fahrenheit degree. The storage criteria and the type of excursion for this vaccine was refrigerator (R). No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
The patient received her COVID19 vaccination, the Moderna mRNA vaccine, on Friday, January 8, 2020 at 10 AM.  She developed some low-grade fevers and fatigue over the next 24 hours, treated with ibuprofen.  However, by Saturday evening, as her fever was slowly improving, she developed some puffiness of her eyes.  The swelling progressed further on Sunday accompanied by low-grade fever and by Monday affecting both eyelids, upper as well as lower, with a burning sensation and some pruritus.  She has noted some desquamation of her skin in that area.  She comes into the office today because of persistent swelling.  She denies any respiratory or throat complaints.  She also states that she has a dry spot on the right side of her mouth, started on Sunday afternoon.  She has not used any fillers and has not had any cosmetic procedures done on her face.   She did develop chondrodermatitis to retinol-A in 2018.  She states that she does have sensitive skin and has used hypoallergenic items intermittently.  She prefers not to place cosmetics on her skin.  She is currently using Victoria's secret Eau so sexy lotion once every other week, typically on her cheeks.  She did use this cosmetic on Sunday on her cheeks, after she developped the swelling of her eyelids.   She does not receive further vaccinations due to personal preferences.  She did receive a Kenalog injection 2018 in her first MTP.  That ingestion contained polysorbitol 80.  She did not have an adverse reaction to the injection.   She was sick with Covid November 2020, diagnosed via positive PCR swab at the urgent care as per patient.
SWELLING TO LEFT EYE LID  AND LOWER LID INCLUDING A POCKET OF FLUID UNDER THE LEFT EYE.
It was 30 to 45 days after my shot. I was experiencing a rash across my stomach. I was in intense pain. I went to the doctor and was diagnosed with Shingles. I was given several medications. It has spread down my entire left side and torso and legs. I cannot remember how long it took to resolve. After my third dose shot, it was Moderna, My under arm swelled up into the size of a golf ball. I could not move my arm for about two weeks. I was in bed for 3 days.
Dose received at 1:15 PM on October 1, 2021.  Began to experience myalgias and arthralgias at 10:00 PM, along with HA, "brain fog"  and fatigue. I took my evening meds and went to bed. At 11, I began to rigor and continued to rigor with fever for the next 7 hours. The fever broke at 5 AM on 10/2/21. I was completely incapacitated the entirety day of 10/2 , only getting up (as a falls risk) to toilet. Interestingly, I had nothing to drink that entire time, but then had polyuria during the morning / afternoon of 10/3 (getting rid of toxins?). Felt moderately better on 10/3. Ate a small bite and drank some water. I would have stayed home from work today, 10/4, but due to project work and meetings, I felt well enough to come to work.
Patient received covid vaccination number one; about one minute post vaccination, patient became very light headed. Upon taking vitals, patient tachycardic at 145 bpm; patient's neck turned red and splotchy; after about 60 seconds, the redness and splotchiness went away; patients blood pressure went up to 170's/90's and heart rate remained in the 130's sustained. Patient was given cold rag and water with no improvement; she was transported to the ED upon request
14AUG92 pt recvd 1st dose of Engerix-B & 3 mins p/inject devel tunnel vision & felt like was going to faint; pt sat down & put head between legs; pt better the same day;
He is immunocompromised; has hypertension.; Booster; This is a spontaneous report received from a contactable consumer for a Pfizer sponsored program. The reporter is the patient. A male patient received bnt162b2 (BNT162B2), administration date 10Sep2021 (Batch/Lot number: unknown) as dose 3 (booster), single for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1), for COVID-19 Immunization; Bnt162b2 (Dose 2), for COVID-19 Immunization. The following information was reported: immunisation (medically significant) with onset 10Sep2021, outcome "unknown", described as "Booster"; immunodeficiency (medically significant), outcome "unknown", described as "He is immunocompromised"; hypertension (non-serious), outcome "unknown", described as "has hypertension.". Event details reported as follow: The patient is seeking guidance if it is possible for him to get vaccination number 4 because it is now available and would like to know if there will be any harm to him because He is immunocompromised and has hypertension. Someone also said that the 5th vaccination will soon be available and if once released he also would like to get it. He already got the first and second doses of the Pfizer vaccine and also the Booster shot dated 10Sep2021.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Began with headache which got continually worse and was eventually accompanied by mild nausea and some fatigue. At 5:30 took Advil 400 mg.  Headache did not respond so 1 hour later I took 1 Percocet 7.5 mg (I had left over from a foot surgery in June). Severe headache continued to persist along with mild nausea. At 10:00pm I took 2 Tylenol and tried to go to bed. Headache was keeping me awake so at 12:30 I took an oxcodone 7.5 mg (prescribed from another foot surgery the year before).  I was finally able to get to sleep.  Woke up this morning (10/5) with stomach upset and mild body aches.  Headache is better. Almost not present now.
Atypical Headache 8 days post J&J vaccine. Woke up with headache at 7:30am and the headache got progressively worse throughout the day. Headache symptoms included head pressure, ear pain, and generalized full body weakness. Went to urgent care at 6:00pm.  Due to ongoing health issues it was hard for the doctor to tell if it was a reaction to the vaccine or not at the time of exam. The doctor discharged me and recommend I go to ER if symptoms progress/get worse.
This spontaneous report was received form a Licensed Practical Nurse, referring to an unspecified number of patients of unknown age and gender. Information regarding concurrent conditions and medical history was not provided. On an unspecified date in March 2016, unspecified number of VARIVAX vaccines were exposed to a temperatures ranged from -1.0 degrees C to -14.8 degree C. After that, on unspecified dates in 2016, the patients were vaccinated with lot numbers: L031066 (expiration date: 18-AUG-2017), L020000 (expiration date 02-JUN-2017), and M000760 (expiration date: 06-JAN-2018. No adverse events were reported. The licensed practical nurse, stated that the vaccines were not previous exposed to temperature excursion. Information was recorded from a data logger. This is one of two reports received from the same source. Additional information has been requested.
Became dizzy, weak and mildly nauseous about 30 minutes after injection.  Extreme fatigue and ringing ears began about 2 hours after vaccination.  Extreme fatigue continued for roughly 40 hours, moderate fatigue for another 24 hours.  About 48 hours after vaccine, developed very mild but continual shortness of breath continuing 24 hours.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 75-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Barrett's oesophagus" (unspecified if ongoing). Concomitant medication(s) included: ELIQUIS; OMEPRAZOLE; METOPROLOL; LEVOTHYROXINE; unspecified probiotic and multivitamin. Known allergies: Not that patient know of. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: Indication: Treatment of COVID-19. Therapeutic measures were taken as a result of drug ineffective, covid-19 which included Paxlovid (treatment start date: 29May2022).  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
No adverse event; Vaccine exposureduring pregnancy; This spontaneous prospective pregnancy report was received from a physician referring to a female patient of an unknown age. The patient's concurrent conditions medical history, drug allergies/ reactions and concomitant medications were not reported. On 17-DEC-2019 (reported as last week), the patient was inadvertently vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (strength, formulation, dose/frequency, route, lot# and expiry date were not reported) (exposure during pregnancy) for prophylaxis. The last menstrual period was estimated as 32 weeks and estimated date of delivery to be on 18-FEB-2020. Initial exposure to hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) was at 31 week(s). The pregnancy outcome was unknown. No additional adverse events reported. The outcome of exposure during pregnancy and no adverse event was unknown.
This is a spontaneous report from a contactable physician. A 13 month old patient completed 3 doses of PREVNAR at 3, 5, 9 months. Relevant history and concomitant medications were not provided. On an unspecified date, the patient developed invasive pneumococcal disease, despite good titer levels (healthy, non-immunogenicity situation). The outcome of the event is unknown.